Heart Failure: A Companion to Braunwald's Heart Disease
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Copyright - p. iv 5. Dedication - p. v 6. Contributors - p. vi 7. Foreword - p. xiv 8. Preface - p. xv 9. Acknowledgments - p. xvi 10. Braunwald’s Heart Disease Family of Books - p. xix 11. Updates to the Book - p. xx 12. Section I. Basic Mechanisms of Heart Failure - p. xx 13. 1. Molecular Basis of Heart Failure - p. 1 14. 2. Cellular Basis for Heart Failure - p. 30 15. 3. Cellular Basis for Myocardial Regeneration and Repair - p. 43 16. 4. Myocardial Basis for Heart Failure: Role of Cardiac Interstitium - p. 62 17. Section II. Mechanisms of Disease Progression in Heart Failure - p. 75.e7 18. 5. Molecular Signaling Mechanisms of the Renin-Angiotensin System in Heart Failure - p. 76 19. 6. Adrenergic Receptor Signaling in Heart Failure - p. 91 20. 7. Role of Innate Immunity in Heart Failure - p. 103 21. 8. Oxidative Stress in Heart Failure - p. 115 22. 9. Natriuretic Peptides in Heart Failure: Pathophysiologic and Therapeutic Implications - p. 127 23. 10. Systolic Dysfunction in Heart Failure - p. 136 24. 11. Alterations in Ventricular Function: Diastolic Heart Failure - p. 151 25. 12. Alterations in Ventricular Structure: Role of Left Ventricular Remodeling and Reverse Remodeling in Heart Failure - p. 166 26. 13. Alterations in the Sympathetic and Parasympathetic Nervous Systems in Heart Failure - p. 181 27. 14. Alterations in the Peripheral Circulation in Heart Failure - p. 201 28. 15. Alterations in Kidney Function Associated With Heart Failure - p. 214 29. 16. Alterations in Skeletal Muscle in Heart Failure - p. 222 30. 17. Alterations in Cardiac Metabolism in Heart Failure - p. 233 31. Section III. Etiologic Basis for Heart Disease - p. 243.e3 32. 18. Epidemiology of Heart Failure - p. 244 33. 19. Heart Failure as a Consequence of Ischemic Heart Disease - p. 254 34. 20. Heart Failure as a Consequence of Dilated Cardiomyopathy - p. 269 35. 21. Restrictive and Infiltrative Cardiomyopathies and Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy - p. 288 36. 22. Cardiac Amyloidosis - p. 301 37. 23. Heart Failure as a Consequence of Hypertrophic Cardiomyopathy - p. 311 38. 24. Heart Failure as a Consequence of Genetic Cardiomyopathy - p. 322 39. 25. Heart Failure as a Consequence of Hypertension - p. 333 40. 26. Heart Failure as a Consequence of Valvular Heart Disease - p. 347 41. 27. Heart Failure as a Consequence of Congenital Heart Disease - p. 363 42. 28. Heart Failure as a Consequence of Viral and Nonviral Myocarditis - p. 376 43. 29. Heart Failure in the Developing World - p. 385 44. 30. Heart Failure and Human Immunodeficiency Virus - p. 395 45. Section IV. Clinical Assessment of Heart Failure - p. 402.e3 46. 31. Clinical Evaluation of Heart Failure - p. 403 47. 32. Cardiac Imaging in Heart Failure - p. 418 48. 33. Biomarkers and Precision Medicine in Heart Failure - p. 449 49. 34. Hemodynamics in Heart Failure - p. 467 50. Section V. Therapy for Heart Failure - p. 486.e2 51. 35. Disease Prevention in Heart Failure - p. 487 52. 36. Acute Heart Failure - p. 501 53. 37. Contemporary Medical Therapy for Heart Failure Patients with Reduced Ejection Fraction - p. 520 54. 38. Management of Arrhythmias and Device Therapy in Heart Failure - p. 549 55. 39. Treatment of Heart Failure with Preserved Ejection Fraction - p. 568 56. 40. Management of Heart Failure in Special Populations: Older Patients, Women, and Racial/Ethnic Minority Groups - p. 586 57. 41. Stem Cell-Based and Gene Therapies in Heart Failure - p. 599 58. 42. Neuromodulation in Heart Failure - p. 608 59. 43. Pulmonary Hypertension - p. 617 60. 44. Heart Transplantation - p. 631 61. 45. Circulatory Assist Devices in Heart Failure - p. 649 62. 46. Cardio-Oncology and Heart Failure - p. 665 63. 47. Disease Management and Telemedicine in Heart Failure - p. 674 64. 48. Management of Comorbidities in Heart Failure - p. 687 65. 49. Quality and Outcomes in Heart Failure - p. 697 66. 50. Decision Making and Palliative Care in Advanced Heart Failure - p. 705 67. Index - p. 719
Heart Failure: A Companion to Braunwald's Heart Disease
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Copyright - p. iv 5. Dedication - p. v 6. Contributors - p. vi 7. Foreword - p. xiv 8. Preface - p. xv 9. Acknowledgments - p. xvi 10. Braunwald’s Heart Disease Family of Books - p. xix 11. Updates to the Book - p. xx 12. Section I. Basic Mechanisms of Heart Failure - p. xx 13. 1. Molecular Basis of Heart Failure - p. 1 14. 2. Cellular Basis for Heart Failure - p. 30 15. 3. Cellular Basis for Myocardial Regeneration and Repair - p. 43 16. 4. Myocardial Basis for Heart Failure: Role of Cardiac Interstitium - p. 62 17. Section II. Mechanisms of Disease Progression in Heart Failure - p. 75.e7 18. 5. Molecular Signaling Mechanisms of the Renin-Angiotensin System in Heart Failure - p. 76 19. 6. Adrenergic Receptor Signaling in Heart Failure - p. 91 20. 7. Role of Innate Immunity in Heart Failure - p. 103 21. 8. Oxidative Stress in Heart Failure - p. 115 22. 9. Natriuretic Peptides in Heart Failure: Pathophysiologic and Therapeutic Implications - p. 127 23. 10. Systolic Dysfunction in Heart Failure - p. 136 24. 11. Alterations in Ventricular Function: Diastolic Heart Failure - p. 151 25. 12. Alterations in Ventricular Structure: Role of Left Ventricular Remodeling and Reverse Remodeling in Heart Failure - p. 166 26. 13. Alterations in the Sympathetic and Parasympathetic Nervous Systems in Heart Failure - p. 181 27. 14. Alterations in the Peripheral Circulation in Heart Failure - p. 201 28. 15. Alterations in Kidney Function Associated With Heart Failure - p. 214 29. 16. Alterations in Skeletal Muscle in Heart Failure - p. 222 30. 17. Alterations in Cardiac Metabolism in Heart Failure - p. 233 31. Section III. Etiologic Basis for Heart Disease - p. 243.e3 32. 18. Epidemiology of Heart Failure - p. 244 33. 19. Heart Failure as a Consequence of Ischemic Heart Disease - p. 254 34. 20. Heart Failure as a Consequence of Dilated Cardiomyopathy - p. 269 35. 21. Restrictive and Infiltrative Cardiomyopathies and Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy - p. 288 36. 22. Cardiac Amyloidosis - p. 301 37. 23. Heart Failure as a Consequence of Hypertrophic Cardiomyopathy - p. 311 38. 24. Heart Failure as a Consequence of Genetic Cardiomyopathy - p. 322 39. 25. Heart Failure as a Consequence of Hypertension - p. 333 40. 26. Heart Failure as a Consequence of Valvular Heart Disease - p. 347 41. 27. Heart Failure as a Consequence of Congenital Heart Disease - p. 363 42. 28. Heart Failure as a Consequence of Viral and Nonviral Myocarditis - p. 376 43. 29. Heart Failure in the Developing World - p. 385 44. 30. Heart Failure and Human Immunodeficiency Virus - p. 395 45. Section IV. Clinical Assessment of Heart Failure - p. 402.e3 46. 31. Clinical Evaluation of Heart Failure - p. 403 47. 32. Cardiac Imaging in Heart Failure - p. 418 48. 33. Biomarkers and Precision Medicine in Heart Failure - p. 449 49. 34. Hemodynamics in Heart Failure - p. 467 50. Section V. Therapy for Heart Failure - p. 486.e2 51. 35. Disease Prevention in Heart Failure - p. 487 52. 36. Acute Heart Failure - p. 501 53. 37. Contemporary Medical Therapy for Heart Failure Patients with Reduced Ejection Fraction - p. 520 54. 38. Management of Arrhythmias and Device Therapy in Heart Failure - p. 549 55. 39. Treatment of Heart Failure with Preserved Ejection Fraction - p. 568 56. 40. Management of Heart Failure in Special Populations: Older Patients, Women, and Racial/Ethnic Minority Groups - p. 586 57. 41. Stem Cell-Based and Gene Therapies in Heart Failure - p. 599 58. 42. Neuromodulation in Heart Failure - p. 608 59. 43. Pulmonary Hypertension - p. 617 60. 44. Heart Transplantation - p. 631 61. 45. Circulatory Assist Devices in Heart Failure - p. 649 62. 46. Cardio-Oncology and Heart Failure - p. 665 63. 47. Disease Management and Telemedicine in Heart Failure - p. 674 64. 48. Management of Comorbidities in Heart Failure - p. 687 65. 49. Quality and Outcomes in Heart Failure - p. 697 66. 50. Decision Making and Palliative Care in Advanced Heart Failure - p. 705 67. Index - p. 719
